Please select the option that best describes you:
When is the best time to try targeted therapy in adult-type diffuse non-IDH glioma?
I have seen targeted therapies used (and studied) more often in the recurrent setting. However, there may also be some rationale for trying BRAF/MEK EGFR MET FGFR or other targeted therapies earlier in the disease course as well.
Answer from: Medical Oncologist at Community Practice
Has this practice changed since posted?
Sign in or Register to read more